Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v7-FR
Language English French
Date Updated 2018-06-29 2018-05-17
Drug Identification Number 00225851 00225851
Brand name DALACIN C FLAVOURED GRANULES DALACIN C FLAVOURED GRANULES
Common or Proper name Dalacin C Flavoured Granules Dalacin C Flavoured Granules
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CLINDAMYCIN CLINDAMYCIN
Strength(s) 75MG 75MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration ORAL ORAL
Packaging size 1x40g 1x40g
ATC code J01FF J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-17 2018-05-17
Estimated end date 2018-06-25
Actual end date 2018-06-28
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments